chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Right arm was warm to touch, raised red rash measuring 8.5 in L x 8in W, tenderness present . Starting 2 inches below right shoulder.  Left arm, warm to touch raised red rash measuring 3in L x 4W, tenderness present. Vaccines were administered on 10/16/2023, mother state during time at home only zytec was administered. Pt was seen in clinic on 10/19/23 for evaluation of reaction by Dr., and second Dr. assessed pt. Treatment: Ibuprofen and Tylenol alternating for discomfort, cool compress. Instructed to continue to monitor adverse reaction, contact office with any changes.
5 hrs p/inject client became listless, did not respond to stimuli as well as mother effected; Taken to Hosp; To be given only DT in future;
3 hours after the vaccine I started running fever. I had a headache and severe pain in my right side. 2:00 am on February 12,2021 I woke up around 3 am in unbelievable pain and swelling starting at the right side of my face, down into my armpit, through my collar bone, chest and back. I had been running a fever and could not keep anything down. The swelling and unimaginable pain led me to go to ER where they treated me for anaphylactic shock. I received intramuscular shot of epi, IV Benadryl, toridol, famitodine. I was sent home, but ended up coming back after about an hour because I had gone into SVT.
Patient had just recovered from the flu weeks prior to injection of Gardasil and Influenza vaccines. The following morning, she woke up with severe body pain, nausea, dizziness, fatigue, brain fog and a severe headache all of which persisted for months. She was seen by several specialists and underwent blood work, brain scans, EEG's, tilt table tests, endoscopies, and gastric emptying scans since 2019 and has been diagnosed with encephalitis, Postural Orthostatic Tachycardia Syndrome (POTS) and slow gastric motility (gastroparesis). Pt has been unable to attend school since 01/29/2019 and has essentially missed all of middle school due to her inability to physically and cognitively attend. She continues to experience dizziness, body pain, nausea with vomiting and recently had a nasogastric tube due to malnutrition and dehydration. Since 2019, she has been seen in the ED almost every two to three weeks for IV fluids. She is currently under the care of a medical team.
Administration of Expired Vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine). On 08-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Administration of Expired Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment details were reported.   This case was linked to MOD-2021-237427 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Aug-2021: Follow-up information include Non-Significant Information
6 y/o who was seen on 20 Oct 2003 with scattered mostly papular and a few papulovesicular rash.  The papules area scattered on the trunk mostly and lower extremities and a few on neck and face.  Treatment was Atarax and Aveeno baths...observe lesions closely for s/s of secondary infection.
DID NOT COMPLETE IMMUNIZATION ONE WEEK PRIOR TO TRAVELING; This spontaneous case report (PVX2019-2586) was received from a consumer on 16-Oct-2019. It described a male consumer who "did not complete immunization one week prior to traveling" (PT: Inappropriate schedule of product administration). The consumer was receiving oral Vivotif for typhoid prophylaxis.  Case report: The consumer will not be completing his Vivotif course one week prior to traveling. He took first dose of Vivotif on 16-Oct-2019 and would be leaving for the endemic area on 22-Oct-2019.  Action taken with Vivotif with respect to event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "did not complete immunization one week prior to traveling" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not complete immunization one week prior to traveling" was considered as not applicable.
Very Bad Sore Arm; Severe Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very Bad Sore Arm) and HEADACHE (Severe Headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Cancer (Stage 3 colon Cancer). Concomitant products included LOSARTAN, METOPROLOL and AMLODIPINE for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Very Bad Sore Arm) and HEADACHE (Severe Headache). On 13-Mar-2021, PAIN IN EXTREMITY (Very Bad Sore Arm) had resolved. At the time of the report, HEADACHE (Severe Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-092757 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-092757:Case for secnd dose
About 30 min after I received the vaccine in my left arm I began to have swelling on the left side of my mouth and tingling throughout my left arm. Took Claritin and eventually the swelling and tingling went away within an hour -hour and a half. That following Tuesday night around 7pm I had the swelling in my lip on the left side again and throughout my chin. This time it took longer after Claritin I felt it still even as I went to bed around 9. When I woke the next morning at 5:30 the swelling was down but the pressure in my chin was still present but did go away completely through the morning.
No adverse event; Expired doses administered/ administered with expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered/ administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 (Spikevax) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered/ administered with expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered/ administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired doses administered/ administered with expired vaccine).    No concomitant medications information was reported.  Number of doses/vials- 35 doses, 4 vials Date the vial was initially stored in the refrigerator- 07-Jun-2022 Expiration date: 01-Apr-2022  Date(s) of administration of the vaccine: 01-Apr-2022, 05-Apr-2022, 06-Apr-2022, 08-Apr-2022, 11-Apr-2022, 12-Apr-2022, 14-Apr-2022, 22-Apr-2022, 09-Jun-2022, 10-Jun-2022, 13-Jun-2022, 18-Jun-2022 and 22-Jun-2022.  The date of individual vaccine administration was not reported and it was unknown whether patient took first dose, second dose or first and or second booster doses.  The vial did not undergo any temperature excursions.  No treatment medications were provided.
Vaccine was in frig with a temperature excursion of higher temperature than package insert recommended.  Was reported to manufacturer.   Sonofi representative said because this was a multi-dose vial it should be considered "not viable".
severe chills that I felt frozen, extreme muscle ache and fatigue. when I left work I had to turn the heat on in my home to 80 degrees. After three hours of sleep and waking up I finally turned off. I slept the entire day of 08/10/20. my feet felt cold and my body ached, I could not keep warm and had a comforter and sheets and no a/c running. I had no appetite and little desire for drinking fluids.  This wiped me out like I was sick. When I reported it to a friend she said that some of her relatives have experienced the same paralyzing sickness like I described after taking the flu shot for this season.  This is the second flu shot in my life time. My first flu shot was 09/2014 from pharmacy and I was fine.  I grew up with all of my vaccines and in a medical household.  I can tell you this year is not a normal reaction, I never have adverse reactions to vaccines and medications.  I am still recovering as I type. I originally requested a day off from work on monday and I am glad that i am off today and tomorrow as well because it will take that long to get my strength back and the body aches and chills to go away.
tested positive after receiving Covid-19 vaccine; tested positive after receiving Covid-19 vaccine; This is a spontaneous report from a contactable nurse. A 38-years-old female patient started received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 18Dec2020 at a single dose for prevention of Covid 19. The patient medical history and concomitant medications were not reported.  The nurse reported that a staff member received the first dose of Covid-19 vaccine on 18Dec2020. Approximately 9 days later, on 27Dec2020, the patient developed/experienced tested positive after receiving Covid-19 vaccine. The seriousness criteria for this event was none. The nurse asked if the patient will be able to receive the second dose and what is the advice for the patient. The outcome of the event was unknown. The reporter considered the relationship of the event to treatment with BNT162B2 as not applicable.  Information about lot/batch number was requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event tested positive Covid-19 based on the known safety profile. However the short duration of 9 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.
Swollen Lymph nodes in neck and under chin, sore throat, slight fever, tiredness
3/28/21 started to have jaw pain. 4/2/21 a lump started to form in neck. 4/3/21 lump in the neck and evening broke out with lesions on the left side of forehead, nose and temple. Went to ER for evaluation, CT scan with contrast. CT confirmed lump was swelling of lymphoid. ER thought maybe shingles, but it crosses over slightly over to the right with lesions.They determined maybe a virus and follow up with a dermatologist.  4/4/21 lesions now on left eye lid. ER visit again to ensure eye is ok, the ER dr. believes its shingles. 4/5/21 visit to dermatology and swab of lesions on face taken (still waiting on results). Dermatology believes some kind of herpes, but not sure. Went to Eye specialist to ensure eye does not have virus on same day. Eye dr believes shingles. Virus is not in the eye, but on left eyelid.
Information has been received from a physician concerning a 70 year old female who was vaccinated with a 1 ml dose of Pneumovax 23 (lot #655587/0882F). Subsequently the patient experienced arm swelling from shoulder to wrist. Unspecified medical attention was sought, this patient may have sought medical attention in the emergency room. This is one of 3 reports from the same source. Additional information has been requested.
Pt received ZOSTAVAX at pharmacy on 10/19/15. Came to office 10/23/15 complaining of reaction to shingles vaccine. Area on back of (L) arm approximately 2-3" above elbow noted have red 1/2 dollars size area w/2  fluid filled blisters inside. Edema noted around red area. Area is painful. Rx BACTRIM DS x 7 days.
When the technician was administering the vaccine  a large part of the dose was seen to flow down the arm. The amount seemed large enough that the decision was made to revaccinate in the other arm with another dose.
alopecia; This case was reported by a other health professional via call center representative and described the occurrence of alopecia in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd January 2020, the patient received the 1st dose of Shingrix (intramuscular). On 20th January 2020, 17 days after receiving Shingrix, the patient experienced alopecia. On an unknown date, the outcome of the alopecia was recovering/resolving.   It was unknown if the reporter considered the alopecia to be related to Shingrix.  Additional details were reported as follows: The patient was a veterinarian. The patient received Shingrix vaccine in right arm  and suffered from alopecia. She saw general practitioner who referred her to a dermatologist. The Emergency room  visit was required. The reporter consented to follow up.
Patient was given dosage of 0.25 ml. of the adult Moderna Vaccine. Patient is 6 months old at this time.  He presented with no symptoms for the initial 15 minutes after having the vaccine.  Primary care provider for patient was notified of medication error.  Mother of patient also contacted and informed of medication error in which adult dose of Moderna was given to the infant.
Pale few minutes after shots administered.  Diarrhea 30 minutes after.  Crying excessively. Pale and vomiting 3 hours after with fever. Turned blue.
I was trying to catch a bus. I was having dizziness, almost fainted while walking. I almost called an ambulance. The next day, I went to urgent care and had a COVID-19 test that came back negative. I had an integrative medicine appointment today. I have had shortness of breath as a preexisting condition before, so I am not sure it is related. I am still experiencing these symptoms today. It is something that is ongoing.
N/V/D; N/V/D; N/V/D; Muscle aches; Joint pains; Mild fever; chills; fatigue/tiredness; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (N/V/D), NAUSEA (N/V/D), VOMITING (N/V/D), MYALGIA (Muscle aches) and ARTHRALGIA (Joint pains) in a 64-year-old female patient who received mRNA-1273 (batch no. 014C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 08-Apr-2021. Concomitant products included PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]) for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced DIARRHOEA (N/V/D), NAUSEA (N/V/D), VOMITING (N/V/D), MYALGIA (Muscle aches), ARTHRALGIA (Joint pains), PYREXIA (Mild fever), CHILLS (chills) and FATIGUE (fatigue/tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (N/V/D), NAUSEA (N/V/D), VOMITING (N/V/D), MYALGIA (Muscle aches), ARTHRALGIA (Joint pains), PYREXIA (Mild fever), CHILLS (chills) and FATIGUE (fatigue/tiredness) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.       The patient reported that she was exposed to Covid-19 on 01-Apr-2021. On 08-Apr-2021, the patient got tested for Covid-19 due to her symptoms. The patient was tested positive on 11-Apr-2021 and finished her quarantine on 18-Apr-2021.   The patient stated that after getting the vaccination, she felt exactly same as when she had Covid-19. The patient also mentioned that when she had Covid-19 she did not have diarrhea.
fever of 104degrees,fever lasted 2-3 days but did not remain 104 degrees. Nausea x 2-3 days redness, swelling, peeling of skin, and hardness @ site(right deltoid.
Developed abdominal pain 5-6 hrs after received Rabies vaccine and JE-VAX in the morning. Headache with fever & chills at night. Went to ER at local hosp. Given TYLENOL for fever & observed. Fever was down in the next morning and no other illness.
Suspected vaccination fialure; Shingles on both feet; This case was reported by a consumer via sales rep and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included kidney transplant.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. At the time of reporting, the patient was struggling with shingles on both feet. The physician performed a biopsy on his kidney and the biopsy came back positive for shingles. The patient was advised he would need a new kidney in the next 12 to 24bmonths. The reporter did not call on this clinic nor did know these providers.  This case was considered as suspected vaccination failure as details regarding vaccination schedule and time to onset for target disease were unknown at the time of reporting.      Lab Comments: On an unknown date, a biopsy was performed on kidney and the biopsy came back positive for shingles.
*I do not know if it is related to vaccine, but was asked if I have been hospitalized since vaccination!* Sudden high blood pressure jump, weeks following change in Atenolol dosage. Headache, fatigue, nausea.  Blood pressure jumped up to 204/116 and heart rate of 145. Sent to ER by my medical provider.   ER ran tests-CT Scan, EKG, blood and urine tests - ER doc told me they were all ok.  Given meds to drop my BP within minutes, two times.  Sent home with script change...no more Atenolol, but now Carvedilol, and Clonidine (as needed, if BP is 150/90 or higher).  Currently monitoring BP for changes.          **Daughter given vaccine same day, within hours of me, has also had her BP spike like this...I don't think she has reported it to this site.**
1st evening fever 103, shortness of breath, heaviness in chest. 2nd day nausea and fatigue and body aches, 3rd day diarrhea extreme fatigue, red rash, swelling, itching , hot to touch at injection site. 4th day chills, night sweats arm still the same, 5th day dizziness, vertigo and head ache. Body aches continuing and extreme fatigue, 8th day body tingling, my skin feels weird that's all I can say. It is hard to describe.  Two weeks later I'm still extremely fatigued, dizzy especially bending over and moving head, General malaise feeling and shortness of breath upon exertion like exercising.
Fever Tmax 102.2. Fussiness. Acetaminophen.
This case was reported by a pharmacist via call center representative and described the occurrence of shoulder pain in a adult female patient who received BOOSTRIX (batch number U5267AA ?, expiry date 11th February 2017) and (batch number U5267AA, expiry date 11th February 2018). Concomitant products included FLUZONE. On 24th October 2017 10:00, the patient received BOOSTRIX (injection) .5 ml. On an unknown date, the dose was an unknown dose. On an unknown date, less than a month after receiving BOOSTRIX, the patient experienced shoulder pain. On an unknown date, the outcome of the shoulder pain was not recovered/not resolved. It was unknown if the reporter considered the shoulder pain to be related to BOOSTRIX. Additional details were provided as follows: On 8th October 2017, the patient received FLUZONE vaccine. The patient received BOOSTRIX vaccine on the left arm. The pharmacist asked if she could be transferred to medical information because she just had a quick question and she would call back to answer additional questions. The batch number (U5267AA) of BOOSTRIX did not exist in sales database and was updated to U5267AA ?. However, clarification was requested.
First vaccination uneventful. Second vaccination uneventful except for expected arm soreness and mild fatigue the following day. However, approximately 2.5 weeks post 2nd vaccination I began to experience peripheral neuropathic symptoms  on the dorsal surfaces of bilateral hands (C6-7 dermatomes). It felt as if I were in a shower with a fine mist hitting both hands - even though the hands themselves were completely dry!. Only occurred while outdoors walking. No pain/numbness/weakness. Lasted roughly 10 days, starting to abate over last 48 hours! Coincidentally, had my first haircut (professional) in a year 3 days ago. I mentioned that it felt good to get out now that I was fully vaccinated. Without suggestion, the hair cutter mentioned that her 81-82 year old mother had had a 2nd vaccination and started feeling ?bugs crawling on the backs of her hands.? My eyes were like saucers because this was a totally-unsolicited remark which closely mimicked the symptoms I was experiencing. Fortunately, they seem to be resolving....!
This spontaneous report as received from a pharmacist refers to a male patient of unknown age with no pertinent medical history. On 02-JUL-2014, the patient was vaccinated with ZOSTAVAX (0.65 ml, subcutaneously, lot# K003595, expiration date: 07-FEB-2015). There was no concomitant therapy. Three days later, on 05-JUL-2014, the patient experienced itching at the injection site. A couple of days after that, on an unknown date in July 2014, the patient developed a rash that looked like a chickenpox and had pustules. No treatment was given for the events. No laboratory diagnostic studies were performed. At the time of the report the patient was still experiencing itching at the injection site and rash was still present. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Persistent vomiting from 3am to about noon on Monday.  Fever of 38.4 ' C. Headache, chills, fatigue. Slept most of the day. Took acetaminophen when able to drink. Drank ginger tea and ate dry toast in the evening. Tuesday, HA controlled with Acetaminophen and Ibuprofen.  Able to eat and increase fluids. Consulted with my PCP who suggested I enter my information. Feeling stronger as time passes. I believe another nights sleep will help.